Literature DB >> 20567647

Propofol in office-based plastic surgery.

Barry L Friedberg1.   

Abstract

Propofol is the nearly ideal agent for office-based plastic surgery. Among all anesthetic agents, only propofol has the ability to elicit happiness in this special group of patients. Cosmetic surgery patients will tolerate discomfort in preference to postoperative nausea and vomiting. Propofol is a powerful antiemetic agent. Patient safety will not be optimized unless the person responsible for the administration of propofol has airway management skills. Dedicated anesthesia providers are highly skilled in airway management. Although the short half-life of propofol is seductive for a fast-acting, rapid emerging anesthetic, interindividual differences in propofol response make measurement of the target organ (i.e., the brain) with a bispectral index (BIS) monitor very important. BIS levels < 45 for > 1 hour are associated with increased 1-year anesthesia mortality thought to be associated with an inflammatory response. The only currently available way to avoid overmedicating with propofol is to monitor with a level of consciousness monitor like BIS.

Entities:  

Keywords:  BIS monitor; Propofol; anesthesia; ketamine; office-based plastic surgery

Year:  2007        PMID: 20567647      PMCID: PMC2884816          DOI: 10.1055/s-2007-979214

Source DB:  PubMed          Journal:  Semin Plast Surg        ISSN: 1535-2188            Impact factor:   2.314


  10 in total

Review 1.  Propofol ketamine anesthesia for cosmetic surgery in the office suite.

Authors:  Barry L Friedberg
Journal:  Int Anesthesiol Clin       Date:  2003

2.  Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy.

Authors:  P E Scuderi; R L James; L Harris; G R Mims
Journal:  Anesth Analg       Date:  2000-12       Impact factor: 5.108

3.  Prevention of postoperative nausea and vomiting--a multimodal solution to a persistent problem.

Authors:  Paul F White
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

4.  Anesthetic management and one-year mortality after noncardiac surgery.

Authors:  Terri G Monk; Vikas Saini; B Craig Weldon; Jeffrey C Sigl
Journal:  Anesth Analg       Date:  2005-01       Impact factor: 5.108

5.  Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes.

Authors:  M H Court; S X Duan; L M Hesse; K Venkatakrishnan; D J Greenblatt
Journal:  Anesthesiology       Date:  2001-01       Impact factor: 7.892

6.  Clonidine premedication decreases propofol consumption during bispectral index (BIS) monitored propofol-ketamine technique for office-based surgery.

Authors:  B L Friedberg; J C Sigl
Journal:  Dermatol Surg       Date:  2000-09       Impact factor: 3.398

7.  Recovery of consciousness after thiopental or propofol. Bispectral index and isolated forearm technique.

Authors:  R Flaishon; A Windsor; J Sigl; P S Sebel
Journal:  Anesthesiology       Date:  1997-03       Impact factor: 7.892

8.  Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists.

Authors:  A Macario; M Weinger; P Truong; M Lee
Journal:  Anesth Analg       Date:  1999-05       Impact factor: 5.108

9.  Which clinical anesthesia outcomes are important to avoid? The perspective of patients.

Authors:  A Macario; M Weinger; S Carney; A Kim
Journal:  Anesth Analg       Date:  1999-09       Impact factor: 5.108

10.  A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.

Authors:  Christian C Apfel; Kari Korttila; Mona Abdalla; Heinz Kerger; Alparslan Turan; Ina Vedder; Carmen Zernak; Klaus Danner; Ritva Jokela; Stuart J Pocock; Stefan Trenkler; Markus Kredel; Andreas Biedler; Daniel I Sessler; Norbert Roewer
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.